期刊文献+

雌激素对多发性硬化保护作用机制的研究进展 被引量:4

下载PDF
导出
摘要 目前认为,多发性硬化(MS)的发病机制兼有自身免疫性损伤和神经变性损伤两方面。大量研究表明,雌激素能够延迟MS和实验性自身免疫性脑脊髓炎(EAE)的病程进展,降低复发率,减少活动病灶,对MS具有明显的保护作用,此作用是通过与雌激素受体(ER)结合实现的。选择性ER配体实验显示,在MS发病的初期及高峰期,雌激素主要与ERα结合,通过免疫调节抑制炎症反应达到神经保护作用;而在疾病后期及缓解期,雌激素主要与ERβ结合。
出处 《山东医药》 CAS 北大核心 2011年第12期111-112,共2页 Shandong Medical Journal
  • 相关文献

参考文献9

  • 1Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis [ J ]. Prog Brain Res, 2009,175 (9) :239-251.
  • 2Seema Tiwari-Woodruff, Laurie Beth J. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER) alpha and ERbeta ligand treatment [J]. Proc Natl Acad Sci U S A, 2007,104 (37) :14813-14818.
  • 3Urich E, Guteher I, Prim M, et al. Autoantibndy-mediated demyelination depends on complement activation but not activatroy Fc-re ceptors [J]. Proc Natl Acad Sci U S A, 2006,103(49):18697-18702.
  • 4Pettersson A, Ciumas C, Chirsky V, et al. Dendritic cells exposed to estrogen in vitro cxhibit therapeutic effects in ongoing experimental allergic encephalomyehris [ J ]. J Neuroimmunol, 2004,156 (1- 2) :58455.
  • 5Bruce-Keller A J, Keeling JL, Keller JN, et al. Anti-inflammatory effects of estrogen on microglial activation [ J]. Endocrinology, 2000,141 (10) :3646-3656.
  • 6Heesen C, Cold SM, Huitinga t, et al. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis [ J ]. Psychoneuroendocrinology, 2007,32(6) :604-618.
  • 7Jasnow AM, Schulkin J, Pfaff DW. Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone mRNA expression in the central amygdala in female mice [ J ]. Hormones and Behavior, 2006,49 ( 2 ) : 197-205.
  • 8Morales LB, Loo KK, Liu HB, et al. Treatment with an estrogen receptor alpha ligand is neumprotective in experimental autoimmune encephalomyelitis [ J]. J Neurosci, 2006,26(25) :6823-6833.
  • 9Liu F, Day M, Bitran D, et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory [J]. Nat Neurosci, 2008,11 (3) :334-343.

同被引文献78

  • 1毛悦时,吕传真.多发性硬化的流行病学[J].国外医学(神经病学.神经外科学分册),2004,31(4):328-331. 被引量:6
  • 2樊永平.中医药辨证治疗多发性硬化的优势与不足[J].北京中医,2005,24(4):209-211. 被引量:49
  • 3陈灏珠.内科学[M].北京:人民卫生出版社,2009:284.
  • 4王德新主译.哈里森临床神经病学[M].北京:人民卫生出版社,2010:344.
  • 5LUBLIN FD, REINGOLD SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis[J]. Neurology, 1996,46(4) : 907-911.
  • 6GUIJARRO C, BENITO-LE6N J, BERMEJO-PAREJA F. Widespread urticaria due to intramuscular interferon beta- 1 a therapy for multiple sclerosis[J].Neurol Sci, 2011, 32(2): 309-311.
  • 7王运良,娄季宇,谢鹏.多发性硬化的基础与临床研究[M].郑州:郑州大学出版社,2009.
  • 8贾建平,陈海,闫欣,等译.神经疾病分级评分量表[M].北京:化学工业出版社,2010:150.
  • 9KURTZKE JF.Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)[J]. Neurology, 1983,33 : 1444-1452.
  • 10SIPE JC, KNOBLER RL, BRAHENY SL, et al. A neurologic rating scale (NRS) for use in multiple sclerosis[J].Neurology, 1984,34 : 1368-1372.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部